> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Abbott Deep Brain Depression Device is Breakthrough Device
- URL: https://www.fdaweb.com/abbott-deep-brain-depression-device-is-breakthrough-device/
- Published: 2022-07-12T12:00:00.000Z
- Updated: 2026-09-14T17:51:25.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152257

FDA has granted breakthrough device designation to an Abbott deep brain stimulation system for use in treatment-resistant depression, which is classified as a form of major depressive disorder. The company [says](https://abbott.mediaroom.com/2022-07-12-Abbott-Receives-FDAs-Breakthrough-Device-Designation-to-Explore-Use-of-Deep-Brain-Stimulation-to-Manage-Severe-Depression?ref=fdaweb.com) its system is a personalized, adjustable therapy that involves implanting leads into targeted areas of the brain. A pulse generator implanted under the skin in the chest is connected to the leads and produces electrical impulses that the company says can modulate abnormal brain activity.